Skip to main content

Table 1 Patient details

From: Assessment of target-mediated uptake with immuno-PET: analysis of a phase I clinical trial with an anti-CD44 antibody

Patient

Gender

Tumour type

CD44 expression (IHC)

Membrane score

H-score

Biopsy location

1

F

Squamous cell carcinoma cervix

3

285

Lung

2

M

Adenocarcinoma oesophagus

2 (focal)

30

Oesophagus

3

M

Colorectal carcinoma

2 (focal)

25

Liver

4

M

Melanoma

3

250

Liver

5

M

Colorectal carcinoma

2

130

Peritoneal

6

F

Squamous cell carcinoma cervix

2 (focal)

65

Cervix

7

M

Basaloid carcinoma tonsil

3

135

Lung

8

M

Squamous cell carcinoma oesophagus

3

210

Neck left

9

M

Colorectal carcinoma

2

85

Liver

10

M

Cholangiocarcinoma

3

200

Liver

11

F

Squamous cell carcinoma ear canal

3

260

Neck left

12

M

Colorectal carcinoma

2 (focal)

35

Liver

13

M

Colorectal carcinoma

3

218

Liver